AIDOT (CEO Jung Jae-hoon) announced on September 14 that, together with the Hanyang University Industry–Academic Cooperation Foundation, it has been selected for an AI-based medical solution/device commercialization demonstration project under the “2023 Data Utilization Medical & Health Ecosystem Creation Program,” hosted by the Gangwon Information & Culture Industry Agency (GICA) and the National IT Industry Promotion Agency (NIPA).
The program supports the development, demonstration, and commercialization of AI-based medical and health services, with the aim of building a digital healthcare innovation ecosystem.
AIDOT formed a consortium with Hanyang University Hospital and was selected based on its business plan for “Development of an AI-Based Digital Otoscope and Laryngoscope System.” The company also signed an agreement with GICA.
AIDOT plans to develop an AI-based diagnostic system for otitis media, oral diseases, and laryngeal (throat) conditions, along with the digital otoscope and laryngoscope hardware. The goal is to create a medical device system that enables fast and convenient at-home screening for ear and oral conditions, and also supports more accurate diagnosis of ear, oral, and laryngopharyngeal conditions by non-ENT clinicians.
According to the company, otitis media is common among infants/young children and older adults, and early diagnosis is important because delayed treatment can lead to serious outcomes. Likewise, delays in professional diagnosis of oral and laryngopharyngeal conditions can progress to illnesses such as deep neck infections, oral cancer, and laryngeal cancer.
A company representative noted that in regions with limited healthcare resources, timely diagnosis and treatment may be difficult. The representative added that AIDOT aims to develop a system that allows quick and convenient at-home diagnosis, and that recommending hospital visits after primary screening could contribute to improving public health and strengthening primary care clinics.
To support the project, GICA will provide the Gangwon Precision Medicine Big Data Platform, and will also support data processing and analysis, medical device regulatory approval, and global expansion.
Professor Jae-ho Jeong of Hanyang University’s Department of Otolaryngology said that if an AI-based clinical support system is produced through this project, it could play an important role in overseas markets where ENT specialty care is hard to access, adding that they will do their best to promote the global dissemination of Korea’s AI medical systems.
AIDOT also said it will develop a product that reflects real-world clinical needs and is clinically valid and commercially viable both domestically and internationally, emphasizing that the development of home-use medical devices can create more opportunities for AI medical devices to be used effectively in everyday life.
Published: September 14, 2023 / MoneyToday / Reporter Lee Doo-ri
